Arthritis Rheumatol
Dr. James R. Seibold, MD
- Publications
- 26
- Clinical trials
- 1
- Industry payments
- $385,112
- State license
- 1
- Year NPI issued
- 2006
- Practice address
- CT
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Seibold's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. James R. Seibold is a rheumatologist in Connecticut
Dr. Seibold practices in Connecticut.
Dr. Seibold's NPI, 1821173337, was assigned on October 25, 2006. Dr. Seibold holds Connecticut license 048454.
- NPI
- 1821173337NPI Registry (opens in a new tab)
- NPI enumeration date
- October 25, 2006
- NPI status
- Active
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dmand AI tracks the EHR system at Dr. James R. Seibold's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Seibold practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Seibold's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. James R. Seibold is one of 109 rheumatologists in Connecticut
Rheumatology is Dr. Seibold's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Seibold is licensed in Connecticut.
Specialties and state licenses
- Rheumatology, ConnecticutPrimary
Rheumatologists near Dr. Seibold
Counts of rheumatologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. James R. Seibold has 26 publications on record
Dmand AI links 26 papers to Dr. Seibold, published from 2010 to 2022. 2013 was the busiest year, with 6. The most frequent topics are Scleroderma, Systemic, Hypertension, Pulmonary and Lung Diseases, Interstitial. Dr. Seibold has published most often in Ann Rheum Dis. Dr. Seibold's most frequent co-authors are Dinesh Khanna, MD, Maureen D. Mayes, MD and Vallerie Victoria McLaughlin, MD.
Dr. Seibold's papers by year, 2010 to 2022
Topics Dr. Seibold writes about most
- Scleroderma, Systemic
- Hypertension, Pulmonary
- Lung Diseases, Interstitial
- Lung
- Disease Progression
- Antihypertensive Agents
- Cardiac Catheterization
- Disease Management
Dr. Seibold's most frequent co-authors
- Dinesh Khanna, MD19 shared papers
- Maureen D. Mayes, MD7 shared papers
- Vallerie Victoria McLaughlin, MD6 shared papers
Recent publications by Dr. Seibold
Autoimmun Rev
See who Dr. Seibold researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Seibold works with, so you can find a warm path to the right rheumatologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. James R. Seibold has worked on 1 clinical trial
Dmand AI links Dr. Seibold to 1 clinical trial. Conditions studied include Dermatomyositis and Polymyositis. Open Payments lists research payments to Dr. Seibold that name 1 trial.
Conditions in Dr. Seibold's trials
- Dermatomyositis
- Polymyositis
Investigators on the most trials with Dr. Seibold
- Rohit Aggarwal, MD1 shared trial
- George Antony Barrio, MD1 shared trial
- Christina Marie Charles-Schoeman, MD1 shared trial
Recent clinical trials with Dr. Seibold
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. James R. Seibold received $385,112 in industry payments from 2016 to 2025
CMS Open Payments shows 165 general payments to Dr. Seibold from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 88% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $261,263. It also lists 13 research payments totaling $30,300 from 2017 to 2020, naming 1 clinical trial.
General payments to Dr. Seibold by program year, 2016 to 2025
General payments to Dr. Seibold by kind, 2016 to 2025
- Consulting fees$339,20288%
- Travel and lodging$21,7416%
- Speaker and faculty fees$17,9245%
- Honoraria$3,3191%
- Food and beverage$2,9251%
Companies that paid Dr. Seibold the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. James R. Seibold's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. James R. Seibold
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. James R. Seibold's NPI number?
Dr. James R. Seibold's NPI number is 1821173337. It was assigned on October 25, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. James R. Seibold?
Dr. James R. Seibold is a rheumatologist in Connecticut. The primary specialty in the NPI Registry is Rheumatology Physician (taxonomy code 207RR0500X).
What is Dr. James R. Seibold's medical license number?
Dr. Seibold holds Connecticut license 048454.
Has Dr. James R. Seibold received payments from drug or device companies?
CMS Open Payments shows $385,112 in general payments to Dr. Seibold from 13 companies from 2016 to 2025. The largest total came from Boehringer Ingelheim Pharmaceuticals, Inc.
How long has Dr. James R. Seibold been practicing?
Dr. Seibold's NPI was assigned in 2006.
Does Dr. James R. Seibold do research?
Dmand AI links 26 publications to Dr. Seibold, published from 2010 to 2022. Dr. Seibold has worked on 1 clinical trial.
Who does Dr. James R. Seibold publish with?
Dr. Seibold's most frequent co-authors are Dinesh Khanna, MD (19 shared papers), Maureen D. Mayes, MD (7 shared papers) and Vallerie Victoria McLaughlin, MD (6 shared papers).
Selling to rheumatology practices?
See rheumatologists in Connecticut by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card